Showing 511-520 of 9418 results for "".
AI is Transforming Google. What’s it Mean for Your SEO Strategy?
https://practicaldermatology.com/topics/practice-management/ai-is-transforming-google-whats-it-mean-for-your-seo-strategy/23674/Quality content remains important as Google search algorithms become better able to “think” about search queries.Six simple tips for an excellent dermatology website design
https://practicaldermatology.com/topics/practice-management/six-simple-tips-for-an-excellent-dermatology-website-design/20068/Is your website design outdated? Are you dreading the redesign? If so, check out this short video from Ekwa Marketing (www.ekwa.com) for tips on making the most of your redesign.Acne Treatment Strategies
https://practicaldermatology.com/conferences/maui-derm-2022/acne-treatment-strategies/20046/Guy F. Webster, MD, PhD shares acne management strategies that are effective for patients and help minimize use of antibiotics. He also discusses the continued role for isotretinoin for the right candidates.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitSetting Things Straight: Medical Myths
https://practicaldermatology.com/conferences/asds-2021/setting-things-straight-medical-myths/20020/Misinformation exists in all of life, including medicine. Physicians who cling to long-held myths may end up providing sub-optimal patient care. Eric Bernstein, MD and colleagues set the record straight.Managing Skin Disease in Cancer Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-skin-disease-in-cancer-patients/19927/Skin reactions to cancer therapeutics can lead to difficult-to-manage rashes. Biologics can present an effective, appropriate option, but dermatologists need to know which biologics to select and when. Anisha Patel, MD provides an overview.Hidradenitis Suppurativa: A Prevalent "Rare" Disease
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-prevalent-rare-disease/19926/Beyond recognizing that hidradenitis suppurativa is far more prevalent than once believed, research has also elucidated disease mechanisms, comorbidities, and pain pathways. Haley Naik, MD provides important updates on this previously neglected disease.Toxic Attitudes Toward Skin Bleaching
https://practicaldermatology.com/conferences/aad-2021/toxic-attitudes-toward-skin-bleaching/19925/Unregulated ingredients intended for skin lightening and bleaching range from the toxic to the simply unproven. Seemal Desai, MD says dermatologists should educate patients about physician-recommended, well-studied treatments and the risks of unregulated products. He highlights increased attention tSARS-CoV-2 and the Skin: Inside the COVID-19 Dermatology Registry
https://practicaldermatology.com/conferences/aad-2021/sars-cov-2-and-the-skin-inside-the-covid-19-dermatology-registry/19921/From COVID Toes to COVID Arms, dermatologic manifestations of SARS-CoV-2 infection and COVID-19 vaccination abound. Esther Freeman, MD, PhD, Director of the COVID-19 Dermatology Registry provides an overview of findings and shares information about the relatively new vaccine registry.Five Ways to Address COVID-Related Staffing Challenges
https://practicaldermatology.com/topics/practice-management/five-ways-to-address-covid-related-staffing-challenges/23442/As practices recover, beyond health and safety issues, it’s essential to manage the personal situations and challenges the pandemic has caused employees.